Trinity Biotech (TRIB) Prepaid Assets (2016 - 2025)

Trinity Biotech (TRIB) posted quarterly Prepaid Assets of $1.7 million for Q4 2025, down 16.42% year-on-year from $2.0 million in Q4 2024, and down 16.42% on a QoQ basis from $2.0 million in Q4 2024.

Trinity Biotech (TRIB) Prepaid Assets (2016 - 2025) Analysis & Trends

Trinity Biotech (TRIB) has reported Prepaid Assets for 7 consecutive years, with $1.7 million the latest figure, recorded in Q4 2025.

  • Quarterly Prepaid Assets fell 16.42% year-over-year to $1.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.7 million (down 16.42% YoY) and the FY2025 annual result came in at $1.7 million, down 16.42% from the prior year.
  • Prepaid Assets fell to $1.7 million in Q4 2025 per TRIB's latest filing, from $2.0 million in the prior quarter.
  • Over the last five years, Prepaid Assets for TRIB reached as high as $2.0 million in Q4 2024 and fell as low as $1.7 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Trinity Biotech 93,750.00 -5.04 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.65 Mn
Dec 31, 2024 1.98 Mn
Dec 31, 2020 1.16 Mn
Dec 31, 2019 576,000.00
Dec 31, 2018 807,000.00
Dec 31, 2017 891,000.00
Dec 31, 2016 3.63 Mn